30322 Federal Register / Vol. 86, No. 107 / Monday, June 7, 2021 / Notices 

delineates, among other items, drug 

products that have been discontinued 

from marketing for reasons other than 

safety or effectiveness. 

FDA will not begin procedures to 

withdraw approval of approved ANDAs 

that refer to these drug products. 

Additional ANDAs for this drug product 

may also be approved by the Agency as 

long as they meet all other legal and 

regulatory requirements for the approval 

of ANDAs. If FDA determines that 

labeling for these drug products should 

be revised to meet current standards, the 

Agency will advise ANDA applicants to 

submit such labeling. 

Dated: May 27, 2021. 

Lauren K. Roth, 

Acting Principal Associate Commissioner for 

Policy. 

[FR Doc. 2021–11800 Filed 6–4–21; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; MultiComponent Application. 

Date: July 21, 2021. 

Time: 12:45 p.m. to 5:15 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Bethesda, MD 20892 (Video Meeting). 

Contact Person: Dario Dieguez, Jr., Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Institute on Aging, National 

Institutes of Health, Gateway Building, Suite 

2W200, 7201 Wisconsin Avenue, Bethesda, 

MD 20892, 301.827.3101, dario.dieguez@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: June 2, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–11880 Filed 6–4–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; NIDDK F99/K99 

Special Emphasis Panel. 

Date: June 23, 2021. 

Time: 12:00 p.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892 (Virtual 

Meeting). 

Contact Person: Peter J. Kozel, Ph.D., 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

6707 Democracy Boulevard, Room 7119, 

Bethesda, MD 20892–5452, 301–594–7271, 

koezelp@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: June 2, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–11881 Filed 6–4–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; PLCO 

Biospecimens Resource U01 SEP. 

Date: July 1, 2021. 

Time: 10:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W102, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Shakeel Ahmad, Ph.D., 

Branch Chief, Research Technology and 

Contract Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W102, Rockville, Maryland 20850, 

240–276–6442, ahmads@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Collaborative Research at the NIH Clinical 

Center (U01). 

Date: July 1, 2021. 

Time: 11:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W240, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Hasan Siddiqui, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609, Medical 

Center Drive, Room 7W240, Rockville, 

Maryland 20850, 240–276–5122, 

hasan.siddiqui@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 86, No. 107 / Monday, June 7, 2021 / Notices 30323 

Dated: June 2, 2021. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–11843 Filed 6–4–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Center for Scientific 

Review Special Emphasis Panel, June 

22, 2021, 10:00 a.m. to June 22, 2021, 

08:00 p.m., National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 which was 

published in the Federal Register on 

May 18, 2021, 86 FR 26931. 

Lawrence Kagemann, Ph.D., 

Larry.Kagemann@Nih.Gov, (301) 480– 

6849, will be the new Contact person, 

replacing Inna Gorshkova as Scientific 

Review Officer. The meeting date and 

location remain the same. The meeting 

is closed to the public. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–11879 Filed 6–4–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[Docket Number USCG–2019–0882] 

BNSF Railway Bridge Across the 

Missouri River Between Bismarck and 

Mandan, North Dakota; Draft 

Environmental Impact Statement 

AGENCY: Coast Guard, DHS. 

ACTION: Notice of availability of draft 

Environmental Impact Statement, 

request for comments, and 

announcement of virtual public 

meeting. 

SUMMARY: The United States Coast 

Guard, as the lead federal agency, 

announces the availability of a draft 

Environmental Impact Statement (EIS), 

in accordance with the National 

Environmental Policy Act of 1969 

(NEPA), Council on Environmental 

Quality (CEQ) NEPA implementing 

regulations, and the National Historic 

Preservation Act (NHPA), evaluating the 

potential environmental consequences 

of permitting the replacement of the 

existing BNSF Railway Bridge across the 

Missouri River between the cities of 

Bismarck and Mandan, ND, or 

constructing a bridge adjacent to the 

existing bridge. The applicant proposes 

to remove the existing structure, which 

is eligible for listing on the National 

Register of Historic Places. The Coast 

Guard is analyzing proposed 

alternatives, through the NEPA and 

NHPA processes, to construct the new 

bridge while retaining the existing 

bridge. The Coast Guard is making the 

draft EIS available for public review and 

requests public comments. 

Additionally, the Coast Guard intends to 

host a virtual public meeting to provide 

additional information to the public and 

to solicit comments on potential issues 

and concerns. 

DATES: Substantive and relevant 

comments must be submitted to the 

online docket via https://

www.regulations.gov/ on or before July 

22, 2021. 

ADDRESSES: You may submit substantive 

and relevant comments identified by 

docket number USCG–2019–0882 using 

the Federal eRulemaking Portal at 

https://www.regulations.gov/. See the 

‘‘Public Participation and Request for 

Comments’’ portion of the 

SUPPLEMENTARY INFORMATION section for 

further instructions on submitting 

comments. 

FOR FURTHER INFORMATION CONTACT: Rob 

McCaskey, Coast Guard District Eight 

Project Officer, 314–269–2381. 

SUPPLEMENTARY INFORMATION: 

I. Background and Purpose 

BNSF Railway Company owns and 

operates the existing bridge that crosses 

the Missouri River between the cities of 

Mandan, and Bismarck, North Dakota. 

With bridge components over 130 years 

old, the in-place structure is 

approaching the end of its useful service 

life. The structure has a history of 

exposure to ice jams and its 

substructure configuration renders it 

potentially susceptible to scour events 

which remove sediment from around 

the bridge abutments and piers. 

Although currently stable, the structure 

has experienced structural issues at both 

approaches in the past, resulting in 

unanticipated substructure movements. 

Since the bridge’s original construction 

in 1882, the east hill slope has begun to 

move which resulted in the slope 

moving the pier west towards the river. 

Multiple remediation efforts to correct 

the pier damage and slope movement 

took place from the early 1900s to the 

mid-1950s. The purpose of the project is 

to construct a new, independent bridge 

across the Missouri River upstream of 

the in-place structure. The new 

structure will provide a significant 

improvement in operational reliability 

and safety, and will provide enhanced 

structural redundancy thereby making it 

less susceptible to damage. As the 

current structure is over 130 years old, 

it requires substantial inspection and 

maintenance, which are disruptive to 

rail service. The new structure will be 

a single-track bridge but have the 

capability to carry a second track in the 

future when and if volumes necessitate 

that addition. 

The BNSF Bismarck Bridge was 

constructed with similar methods in the 

same era as the Brooklyn Bridge. It is an 

iconic landmark that predates official 

North Dakota statehood by 6 years. The 

bridge is eligible for listing in the 

National Register of Historic Places for 

its association with broad patterns of 

railroad, commercial and military 

history of the United States. Because of 

these attributes, certain interest groups 

have expressed a desire to preserve the 

existing bridge. 

The federal bridge statutes, including 

the General Bridge Act of 1946 (33 

U.S.C. 525 et seq.), require that the 

location and plans of bridges in or over 

navigable waters of the United States be 

approved by the Secretary of Homeland 

Security, who has delegated that 

responsibility to the Coast Guard. The 

Missouri River is a navigable water of 

the United States as defined in 33 CFR 

2.36(a). The Coast Guard’s primary 

responsibility regarding BNSF’s 

proposed railroad bridge is to ensure the 

structure does not unreasonably 

obstruct navigation. In exercising these 

bridge authorities, the Coast Guard 

considers navigational and 

environmental impacts, which include 

historic and tribal effects. 

The Coast Guard is the lead federal 

agency for this project and, as such, is 

responsible for the review of its 

potential effects on the human 

environment, including historic 

properties and tribal impacts, pursuant 

to NEPA and NHPA. The Coast Guard 

is, therefore, required by law to ensure 

potential environmental effects are 

carefully evaluated in each bridge 

permitting decision. 

The four alternatives considered for 

the proposed project include different 

span lengths and different distances 

from the current bridge. Specifically, the 

alternatives include: 

• Building a new bridge with 200-foot 

spans and piers 92.5 feet upstream of 

the existing bridge (alternative 

considered keeping the existing bridge 

and removing the existing bridge). 

• Building a new bridge with 400-foot 

spans and piers 92.5 feet upstream of 


khammond on DSKJM1Z7X2PROD with NOTICES